Forefront Medical Technology

Welcome to Forefront Medical Technology’s Blog

Forefront Logo 021516

Looking to learn more about outsourcing medical manufacturing? You’ve reached the right place. Watch our blog for white papers, tips, article links and other information focused on helping medical device manufacturers save time and money without cutting quality. If you’d like to learn more about Forefront Medical’s capabilities, visit our About page or our website: http://www.forefrontmedical.com/.

Q22019 Newsletter

Q2 2019 Forefront newsletterForefront Medical Technology’s latest newsletter looks at outsourcing strategy and lesser known drivers of cost reduction such as leveraging free trade agreement advantages, scalable automation, supply chain realignment and improved logistics efficiency. Read the full issue here.

Outsourcing and Trade Policies

MPOForefront Medical Technology’s President Walter Tarca contributed a column to the June 2019 issue of Medical Product Outsourcing on Outsourcing and Trade Policies. Read the full column here.

Q12019 Newsletter

Q1 2019 Forefront newsletterForefront Medical Technology’s Q1 2019 newsletter provides a quick overview of RoHS 3 and its impact on plasticizers known as phthalates and a look at the “business case” behind good outsourcing strategy. Forefront’s 20% stake in Arrow Medical Limited in the U.K, is also discussed. Read the full issue here.

RoHS III and Phthalates: Can Your Contract Manufacturer Support Changing Requirements?

WP_32 RoHS III and Phthalates_Can Your Contract Manufacturer Support Changing Requirements_Page_1Regulatory changes can have significant impact on product design and market competitiveness. One upcoming example of this impact is the expansion of the European Union’s (EU) list of Restricted or Hazardous Substances, commonly referred to as RoHS 3. The phthalates added to the list are driving a switch from polyvinyl chloride (PVC) to polyurethane (PU) in medical products including tubing, catheters and bags. As with other RoHS directives, regions outside the EU have followed suit in legislation that restricts these substances. And, economies of scale considerations ultimately drive medical device manufacturers to alternatives which are not restricted in any market. Forefront Medical Technology’s latest whitepaper looks at the implications of this legislation and ways a contract manufacturing partner can assist in the effort to fully evaluate the range of acceptable alternatives, the cost impact of a change, and efficient development and commercialization of products utilizing the chosen alternative materials. Read the full paper here.

Visit Forefront At MD&M West Booth #1792

forefrontmedicaltechnology_mdm_600x250

Forefront Medical Technology will be exhibiting at MD&M West at the Anaheim Convention Center on Feb. 5-7. Click here and use code SPECIALFOR406 to register for a free pass to the exhibits and a 20% discount on the conference price.

 

Q4 2108 Newsletter

Q4 2018 Forefront newsletter

Forefront Medical Technology’s Q4 2018 newsletter describes some of the building blocks of world class quality that drive our Quest for Excellence. It also discusses the ways our global approach to quality management helps customers wishing to enter new markets. Read the full issue here.

Extrapolating Extrusion

FFPS-193Forefront Medical Technology’s VP of Business Development, Americas Ron Lilly, recently contributed to a roundtable discussion in Medical Product Outsourcing on extrusion trends and challenges. Read the full article here.